NHS approves pembrolizumab for endometrial cancer
The NHS has greenlit pembrolizumab, a revolutionary immunotherapy drug, offering new hope for women battling advanced endometrial cancer. Discover how this treatment could transform outcomes.
Category : Search result: Keytruda
Page 1 of 1